MD291Z - Method for predicting the development of adverse effects in hearing aids - Google Patents

Method for predicting the development of adverse effects in hearing aids Download PDF

Info

Publication number
MD291Z
MD291Z MDS20100154A MDS20100154A MD291Z MD 291 Z MD291 Z MD 291Z MD S20100154 A MDS20100154 A MD S20100154A MD S20100154 A MDS20100154 A MD S20100154A MD 291 Z MD291 Z MD 291Z
Authority
MD
Moldova
Prior art keywords
development
adverse effects
predicting
hearing aids
risk
Prior art date
Application number
MDS20100154A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Ион АБАБИЙ
Серджиу ПАРИЙ
Ангелина КЯБУРУ
Константин ЖУКОВСКИЙ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20100154A priority Critical patent/MD291Z/en
Publication of MD291Y publication Critical patent/MD291Y/en
Publication of MD291Z publication Critical patent/MD291Z/en

Links

Landscapes

  • Prostheses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

The invention relates to medicine, in particular to otorhinolaringology.Summary of the invention consists in that the method for predicting the development of adverse effects in hearing aids includes the clinical and paraclinical examination, which reveals the following parameters: age of the patient (VP), undergone diseases (FS), evolution of surdity (ES), auditory threshold in the range 0...120 dB (PA), speech recognition index (IA), then it is calculated the discriminant function (F) by the formula:F = -7.927 + 0.144 · VP - 0.476 · FS - 0.975 · ES + 0.073 · PA + 0.065 · IA, and when F>0 it is predicted lack of risk of development of adverse effects, and when F<0 - risk of development of adverse effects.
MDS20100154A 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids MD291Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100154A MD291Z (en) 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100154A MD291Z (en) 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids

Publications (2)

Publication Number Publication Date
MD291Y MD291Y (en) 2010-11-30
MD291Z true MD291Z (en) 2011-07-31

Family

ID=45815233

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100154A MD291Z (en) 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids

Country Status (1)

Country Link
MD (1) MD291Z (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD732Z (en) * 2013-04-12 2014-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for determining the maximum speech intelligibility index

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1041C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prognostication of middle ear latent diseases to children in the first year of life
MD1039C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Diagnosis method of latent inflammatory affections of the midlle ear to children during their first year of life
  • 2010

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1041C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prognostication of middle ear latent diseases to children in the first year of life
MD1039C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Diagnosis method of latent inflammatory affections of the midlle ear to children during their first year of life

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Голованова Л. Е. Методика оценки эффективности слухопротезирования у людей пожилого возраста. Российская *
Голованова Л. Е. Методика оценки эффективности слухопротезирования у людей пожилого возраста. Российская оториноларингология, №1, 2006, с. 56-60 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD732Z (en) * 2013-04-12 2014-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for determining the maximum speech intelligibility index

Also Published As

Publication number Publication date
MD291Y (en) 2010-11-30

Similar Documents

Publication Publication Date Title
EA036698B9 (en) Monoclonal antibody against human lif and use thereof in the treatment of cancer with high level of lif
AU2008298744A8 (en) MiRNA expression in human peripheral blood microvesicles and uses thereof
EA201100440A1 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR CORRECTION OF URIC ACID LEVEL
MX366204B (en) Medical prognosis and prediction of treatment response using multiple cellular signalling pathway activities.
AR081166A1 (en) ANGIOGENESIS FOR THE USE OF PLACENTARY MOTHER CELLS
AR080030A1 (en) TREATMENT OF TYPES OF CANCER OSEO THROUGH THE USE OF PLACENTARY MOTHER CELLS
WO2008073985A3 (en) Laser energy device for soft tissue removal
CL2008002089A1 (en) Compound for regeneration of tissues comprising at least one substance derived from blood and hyaluronic acid and / or at least one compound derived from hyaluronic acid; method for the preparation of said compound.
PH12013501773A1 (en) Nutritional compositions for increasing arginine levels and methods of using same
EP3453723A3 (en) Anti-asic1 antibodies and uses thereof
MX2025010350A (en) Compositions and methods for increasing fetal hemoglobin and treating sickle cell disease
EA201490795A1 (en) 3,4-DESIGNED PYRIDINE CONNECTION, APPLICATION METHODS AND CONTAINING COMPOSITIONS
WO2011151815A3 (en) Implant with body and at least one flute
AU2011208681A8 (en) Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
MY179250A (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention
EA201390703A1 (en) SUBSTITUTED SODIUM-1H-PYRAZOL-5-OLAT
CA2837895C (en) Methods of treating or preventing neurological diseases
AU2016204146A1 (en) Methods of Increasing Neuronal Differentiation Using Antibodies to Lysophoshatidic Acid
MD291Z (en) Method for predicting the development of adverse effects in hearing aids
EP1815856A3 (en) A cancer vaccine
UA110200C2 (en) Agent for treatment and prevention of men genitourinary system disease
WO2014063035A3 (en) Treatment of pain using amnion derived adherent cells
EA200701598A1 (en) METHOD AND COMPOSITION FOR RESTORING EPITELIAL AND OTHER CELLS AND TISSUES
UA93098C2 (en) Liposomal antihelminth agent based on fenasal
Boboshko et al. Peculiarities of hearing prosthetics for the patients suffering tympanophonia

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)